These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effect of aromatase inhibitors on bone metabolism. Folkestad L; Bjarnason NH; Bjerregaard JK; Brixen K Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):3-10. PubMed ID: 19152547 [TBL] [Abstract][Full Text] [Related]
6. [Effect of aromatase inhibitors on bone metabolism]. Folkestad L; Bjerregaard JK; Bjarnason NH; Brixen KT Ugeskr Laeger; 2007 May; 169(19):1774-9. PubMed ID: 17537350 [TBL] [Abstract][Full Text] [Related]
7. [No risk of development of osteoporosis or inhibition of growth in children with asthma treated with inhaled corticosteroids]. Pedersen SE; Bisgaard H; Schiøtz PO Ugeskr Laeger; 2005 Jun; 167(23):2502-3. PubMed ID: 16008003 [No Abstract] [Full Text] [Related]
8. Proton pump-inhibiting drugs, calcium homeostasis, and bone health. Wright MJ; Proctor DD; Insogna KL; Kerstetter JE Nutr Rev; 2008 Feb; 66(2):103-8. PubMed ID: 18254877 [TBL] [Abstract][Full Text] [Related]
9. [Long-term therapy with calcium antagonists. Effects on calcium homeostasis and risk of osteoporosis?]. Ringe JD Med Monatsschr Pharm; 1992 Mar; 15(3):70-2. PubMed ID: 1569911 [No Abstract] [Full Text] [Related]
11. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. De Nijs RN Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694 [TBL] [Abstract][Full Text] [Related]
12. Protein intake: the impact on calcium and bone homeostasis. Isaia G; D'Amelio P; Di Bella S; Tamone C J Endocrinol Invest; 2007; 30(6 Suppl):48-53. PubMed ID: 17721074 [TBL] [Abstract][Full Text] [Related]
13. [Osteoporosis caused by corticoids]. Bevilacqua M Minerva Med; 1969 Jul; 60(57):2859-69. PubMed ID: 5795379 [No Abstract] [Full Text] [Related]
14. [Treatment with corticosteroids, bone mineral density and risk of fractures]. Rosa J Vnitr Lek; 2003 Jan; 49(1):12-4. PubMed ID: 12666423 [No Abstract] [Full Text] [Related]
15. [Thiazolidinediones and skeletal health]. Meier C; Bodmer M; Meier CR; Kraenzlin ME Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930 [TBL] [Abstract][Full Text] [Related]
17. [Contraindications, side-effects and interactions of various groups of drugs]. Fischer AR Ther Ggw; 1982 May; 121(5):325-33. PubMed ID: 7089902 [No Abstract] [Full Text] [Related]
18. [Assessment of bone quality. Bone quality of steroid-induced osteoporosis]. Li M; Saito T; Amizuka N Clin Calcium; 2008 Mar; 18(3):328-35. PubMed ID: 18310820 [TBL] [Abstract][Full Text] [Related]
19. [Strontium ranelate: a novel concept for the treatment of osteoporosis]. Dimai HP Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353 [TBL] [Abstract][Full Text] [Related]
20. Corticosteroids: no drug prevention of fractures needed. Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]